1 Rockefeller Plaza, 10th and 11th Floors, New York, NY 10020 U.S.A.
American Journal of Rheumatology — Open Access Journal
American Journal of Rheumatology is an international, scientific peer-reviewed open access journal published online by SCIREA.
Open Access free for readers, with article processing charges (APC) paid by authors or their institutions.
High visibility: Indexed in the Google Scholar and other databases.
Rapid publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 20 days after submission; acceptance to publication is undertaken in 5 days.
Recognition of reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any SCIREA journal, in appreciation of the work done.
All manuscripts must be prepared in English and are subject to a rigorous and fair peer-review process. Generally, accepted papers will appear online within 5 weeks. The journal publishes original articles and reviews including but not limited to the following fields:
· Aetiology and Pathogenesis
· Archeological/zoological/paleontological evidence of/correlates with disease
· Autoimmune diseases, such as Addison's disease, celiac disease - sprue (gluten-sensitive enteropathy), dermatomyositis, graves disease, hashimoto's thyroiditis, multiple sclerosis, myasthenia gravis, pernicious anemia, reactive arthritis, rheumatoid arthritis, sjogren syndrome, systemic lupus erythematosus, type I diabetes
· Autoimmune features of infections
· Complications，Side effects of medications used to suppress the immune system
· Critical analysis of therapeutic interventions and their pros and cons
· Expectations or prognosis
· Incidence and risk factors
· Laboratory and Radiological Aspects
· New therapeutic strategies in the management of autoimmune diseases difficult to treat
· Pattern recognition aspects of differential diagnosis
· Patterns of disease as population phenomena
· Pro and con opinion pieces
· Rheumatism, such as rheumatic aortic stenosis, rheumatic fever, rheumatoid arthritis, Rheumatoid lung disease, rheumatoid pneumoconiosis
· Signs and tests，include antinuclear antibody tests，autoantibody tests, rheumatoid factor (RF) , CBC, C-reactive protein (CRP), Erythrocyte sedimentation rate (ESR)
· Specific conditions, such as antiphospholipid antibody syndrome, autoimmune hepatitis, autoimmune inner ear disease, autoimmune lymphoproliferative syndrome (ALPS), autoinflammatory diseases, familial mediterranean fever, goodpasture's syndrome, Lambert-Eaton myasthenic syndrome, antiphospholipid syndrome (APS), neuromyelitis optica, paraneoplastic syndromes, Stiff-Person syndrome
· Statistical methodology and its premises for rheumatologists
· Technical aspects of utilizable diagnostic modalities
· Technical aspects of utilizable therapeutic modalities
· The character of diseases affecting bones and joints
· The character of immunologic/autoimmune diseases
· The character of the rare and multisystem diseases
· The history of rheumatology and its principals
· The hotspot in all autoimmune diseases
· The increasing use of biologic drugs and new biologic drugs in evolution
· The premises inherent to rheumatology
· Treatment and Prophylaxis
· Unmet needs in Rheumatology practice
· Update on the diagnosis of anti-phospholipid syndrome
· Updates on the criteria of diagnosis of seronegative spondyloarthropathies and new management strategies
· Updates on the management of vasculitis
